Investor Alert

Company Close Updates Archives | Email alerts

Nov. 19, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP inched 0.83% higher to $1.21 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.87% to 11,904.71 and the Dow Jones Industrial Average DJIA rising 0.15% to 29,483.23. Corbus Pharmaceuticals Holdings Inc. closed $8.57 short of its 52-week high ($9.78), which the company reached on August 31st.

The stock outperformed some of its competitors Thursday, as Fate Therapeutics Inc. FATE fell 0.02% to $49.71, Vanda Pharmaceuticals Inc. VNDA fell 2.73% to $12.47, and Viking Therapeutics Inc. VKTX fell 0.80% to $6.21. Trading volume (2.3 M) remained 2.9 million below its 50-day average volume of 5.2 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.